Close

Novocure (NVCR) Reports Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in NSCLC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP
6. SPY
7. BSX
8. NOW
9. PI
10. ORCL


Go back to Novocure (NVCR) Reports Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in NSCLC

Novocure (NVCR) Climbs 45% Following Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in NSCLC

April 13, 2021 7:59 AM EDT

Novocure (NASDAQ: NVCR) Climbs 45% Following Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in NSCLC

... More